BRENNA GROVE: Open Payments
NPI 1326753856 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,749 in 106 payments from 20 companies in 2025. Trend: 2023 $58 · 2024 $1,969 · 2025 $1,749
Food & beverage: $1,749
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 39 | $427 |
| AstraZeneca Pharmaceuticals LP | 11 | $256 |
| Axsome Therapeutics, Inc. | 8 | $195 |
| Novo Nordisk Inc | 6 | $126 |
| Corium, LLC | 5 | $103 |
| Lilly USA, LLC | 6 | $93 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Amgen Inc. | 5 | $76 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Astellas Pharma US Inc | 2 | $47 |
Products named: VRAYLAR, Auvelity, BREZTRI, Azstarys, CAPLYTA, MOUNJARO, OTEZLA, UBRELVY.
Industry payments across IN — which companies pay providers there.
